166 related articles for article (PubMed ID: 29489091)
41. The Definition and Prevalence of Obesity and Metabolic Syndrome.
Engin A
Adv Exp Med Biol; 2017; 960():1-17. PubMed ID: 28585193
[TBL] [Abstract][Full Text] [Related]
42. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
43. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.
Martínez-Clemente M; Clària J; Titos E
Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):347-53. PubMed ID: 21587068
[TBL] [Abstract][Full Text] [Related]
44. Hepatic fat content is a determinant of metabolic phenotypes and increased carotid intima-media thickness in obese adults.
Zhang H; Ma Z; Pan L; Xu Y; Shao J; Huang Z; Chen Z; Sun Q; Liu C; Lin M; Yang S; Li X
Sci Rep; 2016 Feb; 6():21894. PubMed ID: 26902311
[TBL] [Abstract][Full Text] [Related]
45. Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: does size matter?
Phillips CM; Perry IJ
Atherosclerosis; 2015 Oct; 242(2):399-406. PubMed ID: 26277632
[TBL] [Abstract][Full Text] [Related]
46. [Metabolic obesity in normal weight individuals and cardiovascular disease].
Nowak M; Grzywa M
Pol Merkur Lekarski; 2011 Aug; 31(182):118-21. PubMed ID: 21936351
[TBL] [Abstract][Full Text] [Related]
47. Excess body weight: Novel insights into its roles in obesity comorbidities.
Zhang X; Ha S; Lau HC; Yu J
Semin Cancer Biol; 2023 Jul; 92():16-27. PubMed ID: 36965839
[TBL] [Abstract][Full Text] [Related]
48. Lifestyle modification and endothelial function in obese subjects.
Hamdy O
Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
[TBL] [Abstract][Full Text] [Related]
49. [Metabolic syndrome - a new look at a known problem].
Płaczkowska S; Pawlik-Sobecka L; Kokot I; Piwowar A
Wiad Lek; 2017; 70(5):970-976. PubMed ID: 29203751
[TBL] [Abstract][Full Text] [Related]
50. Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status.
Huh JH; Kim KJ; Kim SU; Han SH; Han KH; Cha BS; Chung CH; Lee BW
Metabolism; 2017 Jan; 66():23-31. PubMed ID: 27923446
[TBL] [Abstract][Full Text] [Related]
51. Healthy obesity.
Wildman RP
Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):438-43. PubMed ID: 19474713
[TBL] [Abstract][Full Text] [Related]
52. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
[TBL] [Abstract][Full Text] [Related]
53. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
Lewis GF; Carpentier A; Adeli K; Giacca A
Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
[TBL] [Abstract][Full Text] [Related]
54. α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2.
Kim HM; Kim YM; Huh JH; Lee ES; Kwon MH; Lee BR; Ko HJ; Chung CH
PLoS One; 2017; 12(6):e0179204. PubMed ID: 28598982
[TBL] [Abstract][Full Text] [Related]
55. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications.
Stefan N; Häring HU; Hu FB; Schulze MB
Lancet Diabetes Endocrinol; 2013 Oct; 1(2):152-62. PubMed ID: 24622321
[TBL] [Abstract][Full Text] [Related]
56. From obesity to diabetes.
Keller U
Int J Vitam Nutr Res; 2006 Jul; 76(4):172-7. PubMed ID: 17243079
[TBL] [Abstract][Full Text] [Related]
57. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
Cusi K
Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
[TBL] [Abstract][Full Text] [Related]
58. Adipose tissue inflammation and insulin resistance: all obese humans are not created equal.
Gauthier MS; Ruderman NB
Biochem J; 2010 Sep; 430(2):e1-4. PubMed ID: 20704568
[TBL] [Abstract][Full Text] [Related]
59. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
60. Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome.
Müller MJ; Lagerpusch M; Enderle J; Schautz B; Heller M; Bosy-Westphal A
Obes Rev; 2012 Dec; 13 Suppl 2():6-13. PubMed ID: 23107255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
